Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ABIRATERONE\ABIRATERONE Cause Disease progression? 7 Reports in FDA Database

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Disease progression have been filed in association with ABIRATERONE\ABIRATERONE. This represents 6.7% of all adverse event reports for ABIRATERONE\ABIRATERONE.

7
Reports of Disease progression with ABIRATERONE\ABIRATERONE
6.7%
of all ABIRATERONE\ABIRATERONE reports
1
Deaths
1
Hospitalizations

How Dangerous Is Disease progression From ABIRATERONE\ABIRATERONE?

Of the 7 reports, 1 (14.3%) resulted in death, 1 (14.3%) required hospitalization.

Is Disease progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ABIRATERONE\ABIRATERONE. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does ABIRATERONE\ABIRATERONE Cause?

Drug ineffective (21) Fatigue (12) Hot flush (10) Death (9) Atrioventricular block complete (6) Long qt syndrome (6) Prostatic specific antigen increased (6) Syncope (6) Anaemia (5) Arthralgia (5)

What Other Drugs Cause Disease progression?

RITUXIMAB (7,282) CYCLOPHOSPHAMIDE (7,100) DOXORUBICIN (6,165) VINCRISTINE (5,252) PREDNISONE (5,096) BEVACIZUMAB (4,653) DEXAMETHASONE (4,545) CARBOPLATIN (4,538) CAPECITABINE (3,808) ETOPOSIDE (3,776)

Which ABIRATERONE\ABIRATERONE Alternatives Have Lower Disease progression Risk?

ABIRATERONE\ABIRATERONE vs ABOBOTULINUMTOXINA ABIRATERONE\ABIRATERONE vs ABRAXANE ABIRATERONE\ABIRATERONE vs ABROCITINIB ABIRATERONE\ABIRATERONE vs ACALABRUTINIB ABIRATERONE\ABIRATERONE vs ACAMPROSATE

Related Pages

ABIRATERONE\ABIRATERONE Full Profile All Disease progression Reports All Drugs Causing Disease progression ABIRATERONE\ABIRATERONE Demographics